How viruses affect tumors and treatment resistance
Part of Infections clinical trials.
This study looks at how viruses like HPV, HIV, and EBV change the environment around tumors and why some cancers resist treatment. If you have one of these virus-related cancers, your tumor samples will be studied to better understand resistance and find new treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have one of these cancers: HPV-related or non-HPV oropharynx cancer, HIV-related or HPV-related non-small cell lung cancer, certain large B-cell lymphomas, or certain anal canal cancers.
- You must have tumor tissue from a biopsy or surgery taken before you started cancer treatment.
- You must be able to sign a consent form and be covered by French social security.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how viruses change the environment around tumors, especially in cancers of the throat, lung, lymph nodes, and anal canal. It aims to understand why some treatments work better for virus-related cancers than others.
This study collects blood and/or tumor-related samples to map how your immune system recognizes cancer. It aims to better understand immune targets and immune cell types, which may help guide future cancer treatments for certain virus-related cancers.
This study looks at virus-related markers and tiny gene regulators (microRNAs) in tumor tissue from people with certain throat cancers caused by human papilloma virus (HPV). It’s observational, meaning it does not change your treatment, but results may help doctors better understand these cancers and how they behave.
This study collects tissue and blood samples from people who have or have been exposed to certain viruses (HIV, KSHV, HPV, EBV, or HTLV-1) or who have developed cancer or precancerous skin lesions. The samples help researchers understand how these viruses may lead to cancer.
This study checks a blood test that looks for HPV tumor DNA to help doctors decide when to start routine treatment after surgery. It may help some people avoid starting treatment too early or too late based on how the test changes after the operation.
This study collects and analyzes tumor tissue to learn what drives certain cancers and growths linked to viruses, HIV, and immune system problems. Results may help researchers understand disease causes and point to better future treatments.
Hear when a new Lymphoma Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.